CA CANATU.HE Canatu Oyj Loading... : Investor Sentiment and Bull/Bear Views

Borrtex argues Canatu's carbon-nanotube EUV pellicles become necessary as chipmakers move to High-NA EUV, because silicon pellicles hit physical limits and High-NA tools raise heat and shorten pellicle lifetimes. The company's licensing-plus-tool model lets customers carry capex while Canatu captures reactor sales, proprietary consumables and per-unit royalties, making pellicle demand scale with exposure intensity rather than wafer volume. Validation catalysts cited include an FST licensing deal seen as a bridge into Samsung's ecosystem, two major Asian semiconductor clients, and growing semiconductor revenue as High-NA adoption advances through the second half of the decade. The author's stated caveat is that this is a small-cap (~€300M) on Nasdaq First North Finland and a deep-tech supply-chain idea, not a clean financial-multiple story.

Author is long Canatu, a small Finnish listed company, because its carbon-nanotube pellicles protect EUV photomasks and become more necessary as EUV moves toward High-NA. The thesis is that pellicles are consumables, High-NA tools burn them several times faster than Low-NA tools, and Canatu's licensing plus reactor/consumables/royalty model can capture recurring economics as pellicle demand grows multiples faster than wafer output into the second half of the decade. Validation signals cited are a licensing deal with FST, often interpreted as a bridge into Samsung's ecosystem, and management references to two major Asian semiconductor clients. Author states the main caveat is that this is a deep-tech, supply-chain-driven idea requiring comfort with semiconductor manufacturing and physics, and a roughly EUR 300M small-cap rather than a clean financial multiple story.

Author has an open long position in small Finnish company Canatu, a carbon nanotube film specialist. The thesis is that Canatu's CNT pellicles for EUV photomasks become increasingly necessary as High-NA EUV ramps because traditional silicon pellicles hit physical limits in heat, deformation, and light transmission. Canatu's model sells specialized reactors and licenses the process to semiconductor supply-chain partners, potentially yielding recurring high-margin licensing and consumables revenue while shifting manufacturing risk to customers. Main stated risk is that the stock is small, illiquid, hard to access on many platforms, and financials still reflect a company transitioning from R&D to industrial scale.

The author says Canatu Oyj is a direct listed way to bet on carbon-nanotube (CNT) adoption across energy storage, semiconductors, and displays, with patents, production capability, and licensing for on-site manufacturing. He argues that even if Donut Labs' claimed solid-state battery is really a supercapacitor with exaggerated claims, CNT adoption continues, and Canatu's roughly €300M market cap makes it small enough that the worst case is buying a solid business. The near-term catalyst cited is Donut's Q1 motorcycle delivery, which would validate the battery/CNT narrative. The main stated risk is that Donut may be exaggerating or that supercapacitors lose energy too quickly, undercutting the near-term battery story.